Healthcare - Biotechnology - NASDAQ - GB
$ 3.08
2.33 %
$ 896 M
Market Cap
-2.7
P/E
Price Target
Average
213.85%
Revenue Forecast
Estimate
319.77%
EBIT
Estimate
--28.23%
Net Income
Estimate
24.79%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Autolus Therapeutics plc
Wall Street analysts predict an average 1-year price target for AUTL of $9.67 , with forecasts ranging from a low of $8 to a high of $11 .
AUTL Lowest Price Target
Wall Street Target
8 USD
159.74%
AUTL Average Price Target
Wall Street Target
9.67 USD
213.85%
AUTL Highest Price Target
Wall Street Target
11 USD
257.14%
REVENUE FORECAST
Revenue Forecast Chart AUTL
EBIT FORECAST
EBIT Forecast Chart AUTL
NET INCOME FORECAST
Net Income Chart AUTL